In vitro synergism between rokitamycin and co-trimoxazole against Streptococcus pyogenes, Streptococcus pneumoniae and staphylococci

Int J Antimicrob Agents. 2008 Feb;31(2):185-7. doi: 10.1016/j.ijantimicag.2007.10.012. Epub 2007 Dec 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Drug Combinations
  • Drug Resistance, Bacterial
  • Drug Synergism*
  • Microbial Sensitivity Tests
  • Miocamycin / analogs & derivatives
  • Miocamycin / pharmacology
  • Streptococcus pneumoniae / drug effects*
  • Streptococcus pneumoniae / growth & development
  • Streptococcus pyogenes / drug effects*
  • Streptococcus pyogenes / growth & development
  • Trimethoprim, Sulfamethoxazole Drug Combination / pharmacology

Substances

  • Anti-Bacterial Agents
  • Drug Combinations
  • Miocamycin
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • rokitamycin